BIOMOL
美國BIOMOL www.biomol.com www.enzolifesciences.com www.enzo.com
Enzo Biochem (ENZ)收購BIOMOL美國資產與旗下兩家英國子公司
美國BIOMOL公司提供用于信號傳導、細胞凋亡、神經科學以及藥物發現等領域酶抑制劑、底物、拮抗劑、多肽、抗體、反義鏈等研究工具
美國BIOMOL 瑞士Enzo
BIOMOL International is a brand of Enzo Life Sciences International, Inc., a wholly owned subsidiary of Enzo Biochem. Incorporating the Alexis Biochemicals and BIOMOL brands, Enzo Life Sciences is organized to lead in the development, production, marketing, and sales of innovative life science research reagents
worldwide.
BIOMOL International has been a leader and an innovator in providing superior, cutting-edge reagents for biomedical research for over 25 years. BIOMOL has been focused on researcher’s success since the release of leukotrienes in 1983, through the introduction of the first pathway-specific signal transduction catalog to today’s offering of over 3500 products and services.
Within Enzo Life Sciences, BIOMOL is a major research, development and production center, developing and producing innovative products for:
• Signal Transduction
• Lipid Signaling
• Post Translational Modifications
• Proteolysis
• Ubiquitin & Ubiquitin-like Protein Signalling
With production facilities in the Greater Philadelphia region and Exeter, U.K. (formerly AFFINITI Research Products, Ltd.), BIOMOL maintains in-house laboratories staffed with an experienced research & development team of organic chemists, biochemists, cell biologists, pharmacologists and molecular biologists with the expertise to develop and support the innovative products that biomedical research requires. Capabilities include organic chemical synthesis, peptide synthesis, recombinant protein production, antibody production and assay development.
